NCT07859423Phase 2, phase 3Not yet recruiting

A Study to Investigate AG-236 in Subjects ≥18 Years of Age With Polycythemia Vera

Study sponsor: Agios Pharmaceuticals, Inc. · AGIO

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2030-08Estimated
Enrollment · participants245Estimated
Source updated2026-10-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.